Actinogen Medical

Actinogen Medical EBIT per Share

The EBIT per Share of Actinogen Medical (ACW.AX) as of Oct 11, 2026 is -0.01 AUD.

EBIT per Share

-0.01AUD

YoY

81.67%

Last updated:

EBIT per Share of Actinogen Medical is 2026 -0.01 AUD. EBIT per Share of Actinogen Medical was 2025 -0.00 AUD. It decreases by 81.67% lower compared to the previous year.

The Actinogen Medical EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.00 AUD
Jan 1, 2022
-0.01 AUD
Jan 1, 2023
-0.01 AUD
Jan 1, 2024
-0.44 AUD
Jan 1, 2025
-0.00 AUD
Jan 1, 2026
-0.01 AUD
Jan 1, 2027 (e)
-0.00 AUD
Jan 1, 2030 (e)
-0.00 AUD
The Actinogen Medical EBIT per Share history
YEAREBIT per ShareYoY
est-0.00AUD+81.28%
est-0.00AUD-97.08%
-0.01AUD+81.67%
-0.00AUD-98.94%
-0.44AUD+6,385.52%
-0.01AUD-1.80%
-0.01AUD+119.25%
-0.00AUD-46.59%
-0.01AUD-27.17%
-0.01AUD-8.44%
-0.01AUD+21.58%
-0.01AUD-41.55%
-0.01AUD+39.21%
-0.01AUD+486.62%
-0.00AUD-48.92%
-0.00AUD-87.96%
-0.02AUD-13.25%
-0.03AUD-35.13%
-0.04AUD+17.34%
-0.04AUD+53.47%
-0.02AUD—
Access this data via the Eulerpool API
Get Free API Key

Actinogen Medical Stock analysis

What does Actinogen Medical do? Actinogen Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Actinogen Medical stock

EBIT per Share of Actinogen Medical is -0.01 AUD in 2026.

On Eulerpool you can find the complete historical development of EBIT per Share Actinogen Medical since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Actinogen Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Actinogen Medical